We are live on ! Find out more
QI

Qtron Investments Portfolio holdings

AUM $738M
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+32.56%
3 Year Est. Return
+110.61%
5 Year Est. Return
+163.35%
10 Year Est. Return
AUM
$447M
AUM Growth
+$4.62M
Cap. Flow
+$15.5M
Cap. Flow %
3.45%
Top 10 Hldgs %
25.61%
Holding
385
New
58
Increased
83
Reduced
65
Closed
51

Top Buys

Rank Stock Value
1
VALE icon
Vale
VALE
+$3.13M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
AAPL icon
Apple
AAPL
+$1.39M
4
NOW icon
ServiceNow
NOW
+$1.27M
5
MSFT icon
Microsoft
MSFT
+$1.27M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Consumer Discretionary 15%
3 Healthcare 11.93%
4 Financials 11.62%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IX icon
301
ORIX
IX
$43.5B
$287K 0.06%
+14,355
New +$293K
NVCR icon
302
NovoCure
NVCR
$1.91B
$286K 0.06%
+3,446
New +$254K
CDNS icon
303
Cadence Design Systems
CDNS
$93.4B
$282K 0.06%
1,717
FLO icon
304
Flowers Foods
FLO
$1.57B
$280K 0.06%
10,879
PNR icon
305
Pentair
PNR
$11B
$279K 0.06%
5,150
CSX icon
306
CSX Corp
CSX
$93.1B
$274K 0.06%
7,326
STLD icon
307
Steel Dynamics
STLD
$37.6B
$267K 0.06%
+3,200
New +$216K
ZS icon
308
Zscaler
ZS
$27.3B
$266K 0.06%
1,103
ARW icon
309
Arrow Electronics
ARW
$10.4B
$262K 0.06%
2,207
WBS icon
310
Webster Financial
WBS
$12.8B
$259K 0.06%
+4,621
New +$274K
LPX icon
311
Louisiana-Pacific
LPX
$5.49B
$258K 0.06%
+4,158
New +$287K
REGN icon
312
Regeneron Pharmaceuticals
REGN
$80.8B
$254K 0.06%
+364
New +$230K
AVTR icon
313
Avantor
AVTR
$9.19B
$249K 0.06%
7,364
EXAS
314
DELISTED
Exact Sciences
EXAS
$246K 0.06%
+3,516
New +$257K
OTIS icon
315
Otis Worldwide
OTIS
$28.2B
$237K 0.05%
3,076
-2,970
-49% -$237K
BNS icon
316
Scotiabank
BNS
$108B
$231K 0.05%
3,220
UGI icon
317
UGI
UGI
$7.33B
$231K 0.05%
6,383
-13,541
-68% -$542K
SLVM icon
318
Sylvamo
SLVM
$1.63B
$226K 0.05%
+6,789
New +$225K
BCE icon
319
BCE
BCE
$21.2B
$224K 0.05%
4,040
SCHW
320
Charles Schwab
SCHW
$187B
$217K 0.05%
+2,572
New +$226K
RCM
321
DELISTED
R1 RCM Inc. Common Stock
RCM
$216K 0.05%
8,081
LEVI icon
322
Levi Strauss
LEVI
$9.39B
$214K 0.05%
+10,832
New +$234K
STLA icon
323
Stellantis
STLA
$20.8B
$214K 0.05%
12,968
ITUB icon
324
Itaú Unibanco
ITUB
$87.5B
$213K 0.05%
42,212
SLB icon
325
SLB Ltd
SLB
$75B
$210K 0.05%
+5,083
New +$199K

Similar funds

Qtron Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Qtron Investments held 385 positions worth $447M, up 1% from $443M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Qtron Investments deployed $15.5M of net new capital in Q1 2022, opening 58 new positions and adding to 83 existing holdings. Its largest new stake was Bristol-Myers Squibb: 21,083 shares worth $1.54M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NetEase, an estimated $2.43M trimmed.

  • Qtron Investments's largest Q1 2022 buy was Bristol-Myers Squibb: 21,083 shares worth $1.54M.
  • Qtron Investments added most to Vale in Q1 2022, an estimated $3.13M increase.
  • Qtron Investments's biggest Q1 2022 reduction was NetEase, cutting an estimated $2.43M.
  • Qtron Investments fully exited Johnson Controls International in Q1 2022, selling an estimated $1.32M.
  • Qtron Investments's ten largest holdings make up 26% of its $447M portfolio in Q1 2022.
  • Qtron Investments opened 58 new positions and closed 51 in Q1 2022.
  • Qtron Investments's portfolio value rose 1% quarter-over-quarter to $447M.

Based on Qtron Investments's 13F filing for Q1 2022, filed 5 May 2022.